EUVIMEDEUVIMED entdecken
Crossref

Single-cell analysis identifies ATC-like cells driving progression in relapsed follicular thyroid carcinoma

Jian Chen iD, Lei Xu, Tian-Yu Liu, Wei-Jian Chen, Bao Dai, Shi-Kuo Rong, Zi-Teng Lan, Lin-He Wang, Yong-Chen Liu, Jing-Hua Li iD, Lu Li iD, Ze-Yu Wu iD

Endocrinology · 2026

DOI: 10.1210/endocr/bqag012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Jian Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Hernia Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University…. Hauptthemen laut MEDLINE: Adenocarcinoma, Follicular, Thyroid Neoplasms, Neoplasm Recurrence, Local, Thyroid Carcinoma, Anaplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China, Guangdong Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicular thyroid carcinoma (FTC) is prone to early distant metastasis and has a poor prognosis compared with papillary thyroid carcinoma (PTC). This study aimed to unravel the cellular and molecular mechanisms underlying FTC progression and its transformation into the aggressive anaplastic thyroid carcinoma (ATC). Through single-cell RNA sequencing (scRNA-seq) profiling of 46 739 cells from PTC, follicular variant PTC (FVPTC), relapsed FTC (RFTC), and ATC, we reconstructed a comprehensive molecular trajectory of thyroid carcinoma progression. Our analysis revealed that PTC, FVPTC, and FTC possess distinct yet converging pathways of dedifferentiating into ATC, with FVPTC also able to progress to FTC. In RFTC, we identified a unique cluster of cells exhibiting ATC molecular characteristics. These cells interact with endothelial cells and fibroblasts mainly via the COL9A3-integrin α1β1 complex and may exhibit high metabolic and proliferative potential. UBE2C was identified as a specific marker for this population, which we termed “ATC-like cells.” Functional validation in vitro and in vivo confirmed that UBE2C was markedly upregulated in FTC and was associated with adverse clinical outcomes. Mechanistically, UBE2C promoted cell proliferation and tumor growth, and regulated D-arginine and D-ornithine metabolism, glutathione metabolism, glycerophospholipid metabolism and tryptophan metabolism in FTC. This reveals a previously unrecognized population of ATC-like cells in RFTC marked by high UBE2C expression. UBE2C contributes to FTC progression by enhancing proliferation and modulating key metabolic pathways, suggesting it as both a critical biomarker of aggressive disease and a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma, FollicularThyroid NeoplasmsNeoplasm Recurrence, LocalThyroid Carcinoma, AnaplasticHumansAnimalsMiceSingle-Cell Gene Expression AnalysisDisease Models, AnimalDisease ProgressionCell Transformation, NeoplasticRNA-SeqUbiquitin-Conjugating EnzymesCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

UBE2Canaplastic thyroid carcinomacancer metabolismfollicular thyroid carcinomasingle-cell RNA sequencing

Substanzen

UBE2C protein, humanUbiquitin-Conjugating Enzymes

Autor:innen und Institutionen

  • Department of Thyroid and Hernia Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Department of Laboratory, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
  • Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, School of Medical Technology, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523808, China.

ORCID-Profile: Jian Chen, Jing-Hua Li, Lu Li, Ze-Yu Wu

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China
  • Guangdong Medical Research Foundation

Zitieren

APA

Chen, J., Xu, L., Liu, T. Y., Chen, W. J., Dai, B., Rong, S. K., Lan, Z. T., Wang, L. H., Liu, Y. C., Li, J. H., Li, L., & Wu, Z. Y. (2026). Single-cell analysis identifies ATC-like cells driving progression in relapsed follicular thyroid carcinoma. Endocrinology. https://doi.org/10.1210/endocr/bqag012

Vancouver

Chen J, Xu L, Liu TY, Chen WJ, Dai B, Rong SK, et al. Single-cell analysis identifies ATC-like cells driving progression in relapsed follicular thyroid carcinoma. Endocrinology. 2026. doi:10.1210/endocr/bqag012

BibTeX
@article{Chen2026,
  author = {Chen, Jian and Xu, Lei and Liu, Tian-Yu and Chen, Wei-Jian and Dai, Bao and Rong, Shi-Kuo and Lan, Zi-Teng and Wang, Lin-He and Liu, Yong-Chen and Li, Jing-Hua and Li, Lu and Wu, Ze-Yu},
  title = {Single-cell analysis identifies ATC-like cells driving progression in relapsed follicular thyroid carcinoma},
  journal = {Endocrinology},
  year = {2026},
  doi = {10.1210/endocr/bqag012}
}
Kostenlos starten →